Effect of intracoronary nitroglycerin administration on phasic pattern and transmural distribution of flow during

M Goto1, A E Flynn, J W Doucette

  • 1Department of Medical Engineering and Systems Cardiology, Kawasaki Medical School, Kurashiki, Japan.

Circulation
|June 1, 1992
PubMed

Insights

Intracoronary nitroglycerin may fail to relieve angina due to increased systolic reverse flow, which impairs subendocardial blood flow despite increased subepicardial flow in ischemic hearts.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology

Background:

  • Nitroglycerin effectively relieves myocardial ischemia.
  • Intracoronary nitroglycerin can fail to alleviate angina and may negatively impact subendocardial blood flow.
  • Mechanisms underlying these effects require investigation.

Purpose of the Study:

  • To investigate the direct effects of nitroglycerin on coronary circulation in ischemic hearts.
  • To elucidate the relationship between nitroglycerin administration and coronary blood flow patterns.

Main Methods:

  • Utilized an 80-channel, 20-MHz pulsed Doppler ultrasound flowmeter to measure intramyocardial coronary arterial flow.
  • Employed radioactive microspheres to assess transmyocardial blood flow distribution.
  • Studied effects in anesthetized open-chest dogs with induced coronary artery stenosis.

Main Results:

  • Nitroglycerin administration decreased distal systolic and diastolic pressures in stenosed coronary arteries.
  • Nitroglycerin increased diastolic forward flow but significantly augmented systolic reverse flow.
  • Subepicardial flow increased with nitroglycerin, while subendocardial flow did not, leading to a reduced subendocardial-to-subepicardial flow ratio.

Conclusions:

  • Increased systolic reverse flow following intracoronary nitroglycerin is a key factor.
  • This augmented systolic reverse flow is closely linked to the failure of subendocardial blood flow to improve.
  • The findings suggest a potential mechanism for nitroglycerin's limited efficacy in certain ischemic conditions.
Abstract

Related Concept Videos

Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...